Maidstone & Tunbridge Wells NHS Trust Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2001
NCT00025090
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Maidstone Hospital, Dept. Rheumatology | Maidstone & Tunbridge Wells NHS Trust

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anus Neoplasms (Phase 3)

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5